Use of randomised trials to decide when to monitor response to new treatment

被引：22
作者：
Bell, Katy J. L. [1 ]
Irwig, Les [1 ]
Craig, Jonathan C. [1 ]
Macaskill, Petra [1 ]
机构：
[1] Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2008年 / 336卷 / 7640期
关键词：
D O I：
10.1136/bmj.39476.623611.25
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：361 / 365
页数：9
相关论文
共 11 条
  • [1] Monitoring osteoporosis therapy with bone densitometry - Misleading changes and regression to the man
    Cummings, SR
    Palermo, L
    Browner, W
    Marcus, R
    Wallace, R
    Pearson, J
    Blackwell, T
    Eckert, S
    Black, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (10): : 1318 - 1321
  • [2] Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs
    Cummings, SR
    Karpf, DB
    Harris, F
    Genant, HK
    Ensrud, K
    LaCroix, AZ
    Black, DM
    [J]. AMERICAN JOURNAL OF MEDICINE, 2002, 112 (04) : 281 - 289
  • [3] Monitoring in chronic disease: a rational approach
    Glasziou, P
    Irwig, L
    Mant, D
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7492): : 644 - 648
  • [4] GLASZIOU P, 2007, EVIDENCE BASED MED M, P245
  • [5] Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
    Grundy, SM
    Cleeman, JI
    Merz, CNB
    Brewer, HB
    Clark, LT
    Hunninghake, DB
    Pasternak, RC
    Smith, SC
    Stone, NJ
    [J]. CIRCULATION, 2004, 110 (02) : 227 - 239
  • [6] The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
    Moher, D
    Schulz, KF
    Altman, DG
    [J]. LANCET, 2001, 357 (9263) : 1191 - 1194
  • [7] Regression to the mean: treatment effect without the intervention
    Morton, V
    Torgerson, DJ
    [J]. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2005, 11 (01) : 59 - 65
  • [8] A CONSUMERS GUIDE TO SUBGROUP ANALYSES
    OXMAN, AD
    GUYATT, GH
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 116 (01) : 78 - 84
  • [9] Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertension
    Sellin, Lorenz
    Stegbauer, Johannes
    Laeis, Petra
    Rump, Lars C.
    [J]. JOURNAL OF HYPERTENSION, 2005, 23 (11) : 2083 - 2092
  • [10] Individual therapy: New dawn or false dawn?
    Senn, S
    [J]. DRUG INFORMATION JOURNAL, 2001, 35 (04): : 1479 - 1494
12